Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-05-23 @ 10:06 AM
Study NCT ID:
NCT01233505
Status:
TERMINATED
Last Update Posted:
2014-04-02
First Post:
2010-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adenocarcinoma of the Pancreas | View |
| None | Adenocarcinoma of the Stomach | View |
| None | BRCA1 Mutation Carrier | View |
| None | BRCA2 Mutation Carrier | View |
| None | Ovarian Mucinous Cystadenocarcinoma | View |
| None | Recurrent Breast Cancer | View |
| None | Recurrent Colon Cancer | View |
| None | Recurrent Gastric Cancer | View |
| None | Recurrent Ovarian Epithelial Cancer | View |
| None | Recurrent Ovarian Germ Cell Tumor | View |
| None | Recurrent Pancreatic Cancer | View |
| None | Recurrent Rectal Cancer | View |
| None | Stage IA Breast Cancer | View |
| None | Stage IB Breast Cancer | View |
| None | Stage II Breast Cancer | View |
| None | Stage IIIA Breast Cancer | View |
| None | Stage IIIB Breast Cancer | View |
| None | Stage IIIC Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Stage IV Colon Cancer | View |
| None | Stage IV Gastric Cancer | View |
| None | Stage IV Ovarian Epithelial Cancer | View |
| None | Stage IV Ovarian Germ Cell Tumor | View |
| None | Stage IV Pancreatic Cancer | View |
| None | Stage IV Rectal Cancer | View |
| None | Unspecified Adult Solid Tumor, Protocol Specific | View |
Keywords: